How the contract works
This contract settles based on whether Russia carries out an intentional, non-combat detonation of a device that produces a nuclear chain reaction, of any yield, by 31 December 2026. Accidents, radiological dispersal devices without a chain reaction, and tests by other countries do not count, but an unclaimed detonation can still resolve the market Yes if credible reporting broadly attributes it to Russia. A contract pays $1 if that happens and nothing if it does not; a price of 0.30, for example, would mean the market sees roughly three chances in ten. The market resolves by 1 January 2027 based on a broad consensus of credible reporting from news organizations, arms control monitors, and government statements, and a position can generally be sold before then at whatever price the market has moved to.
Yes6%
No94%
Probability
How the price has moved
The market is currently tracked on a single venue, Polymarket, with $116,038 in total volume and a price of 6%. No day-over-day or week-over-week move data is available across venues for this snapshot, and no second venue exists yet to show a cross-market spread. A single low-volume market sitting at a low single-digit-to-mid-single-digit price generally reflects a broad view among active participants that the event is unlikely without dismissing it entirely, rather than a market reacting to a specific recent trigger.
Analysis
Context
Russia's last acknowledged nuclear test was in October 1990, at the Novaya Zemlya archipelago in the Arctic, before the Soviet Union signed on to an informal global testing halt. The 1996 Comprehensive Nuclear-Test-Ban Treaty (CTBT) never entered into force because several states, including the United States, never ratified it, but Russia had ratified it in 2000. In November 2023 the Russian parliament voted to revoke that ratification, explicitly citing the US failure to ratify, which put Moscow's formal legal status closer to Washington's than to the treaty's supporters.
Since then, arms-control researchers and satellite-imagery analysts have periodically flagged construction and vehicle activity at the Novaya Zemlya site, which Russia has never fully mothballed. Officials in Moscow, including President Vladimir Putin, have said Russia could resume testing if the United States does so first, framing any move as reciprocal rather than unilateral. The other major bilateral constraint, the New START treaty limiting deployed US and Russian strategic warheads, is due to expire on 5 February 2026, removing one of the last formal caps on the two arsenals just as this market's window closes.
No other state has conducted a confirmed nuclear test since North Korea's last acknowledged detonation in 2017. A Russian test would be the first by a major nuclear power in over three decades and would land squarely inside an already tense period of the Ukraine war, NATO force posture debates, and US domestic discussion about its own testing readiness.
The consensus price across venues sits at 6%, drawn entirely from Polymarket, which is currently the only market pricing this question with $116,038 in total volume. That is a modest amount for a geopolitical contract with this much potential news sensitivity, which means the price reflects a relatively small number of active positions rather than a deep, continuously arbitraged market. A single-venue price with limited volume tends to move more sharply on individual news events than a deeply traded one, so the 6% figure should be read as a working estimate rather than a settled consensus.
The core argument for a low price is historical and structural. Russia has abstained from live nuclear testing for 36 years, relying instead on subcritical experiments and computer simulation to maintain its stockpile, a path that avoids the diplomatic fallout, sanctions risk, and technical exposure of a full test. Even during the most acute phases of the Ukraine war, including explicit Russian nuclear rhetoric in 2022 and 2023, Moscow has not crossed that line, suggesting a high threshold that a single year of continued tension is unlikely to breach on its own.
What keeps the price above a negligible level is the erosion of the legal and political guardrails that used to make testing costly to justify domestically. The Duma's 2023 vote to de-ratify the CTBT removed a formal obligation, even if Russia remains a signatory, and officials have repeatedly tied any resumption to reciprocity with the United States. Reports of activity at Novaya Zemlya, while inconclusive on their own, are the kind of evidence that arms-control monitors watch precisely because test-site preparation typically precedes an actual detonation by months, not days.
The expiration of New START on 5 February 2026 is the clearest scheduled inflection point inside this market's window. Its lapse removes verification and warhead-limit obligations that have applied since 2011, and a period without any bilateral strategic arms treaty is the kind of environment in which either side might feel less constrained about signaling through testing. Whether that translates into an actual detonation depends heavily on decisions made in Washington as much as Moscow, since Russian officials have framed their own restraint as conditional on US behavior.
What moves the probability
36-year test moratorium
Russia has not conducted a nuclear test since 1990 and has relied on subcritical experiments and simulation instead. That long a track record of restraint, even through prior crises, weighs the price down toward a low probability.
CTBT de-ratification, 2023
The Duma's vote to withdraw Russia's ratification of the Comprehensive Nuclear-Test-Ban Treaty removed a formal domestic legal obstacle to testing. It does not make a test likely on its own, but it lowered the institutional barrier, pushing the price up modestly from where it would sit under full treaty commitment.
Novaya Zemlya site activity
Periodic satellite-imagery reports of construction and vehicle movement at Russia's Arctic test site are the type of evidence arms-control monitors treat as an early warning indicator. Any credible new imagery showing test-shaft preparation would likely move the price up sharply.
New START expiration, 5 February 2026
The bilateral treaty capping deployed US and Russian strategic warheads lapses inside this market's window, removing a structural constraint that has applied since 2011. Its expiration raises the ceiling on what either side might consider without a formal agreement, a modest upward pressure on the probability.
Reciprocity conditioned on US action
Russian officials, including Putin, have said resumption would follow rather than precede any US test. That conditional framing means the probability here is partly a function of a separate, related question about US testing policy, and a US move would be the single most likely trigger for a shift.
The case for
- The Duma revoked Russia's ratification of the CTBT in November 2023, removing a formal legal barrier that existed for 23 years.
- Reports of renewed construction and activity at the Novaya Zemlya test site have surfaced periodically since 2022, the kind of evidence that typically precedes preparations for an actual test.
- New START, the last treaty capping US and Russian strategic warheads, expires on 5 February 2026, removing a structural constraint during this market's window.
- Russian officials have said they would resume testing if the United States does so first, meaning a US test or announcement could serve as the trigger.
The case against
- Russia has not conducted a nuclear test since 1990, a 36-year record maintained even through the most acute phases of the Ukraine war.
- A test would trigger severe diplomatic and economic isolation, including from partners like China and India that Russia currently relies on to blunt Western sanctions.
- Stockpile stewardship needs can be met through subcritical experiments and simulation, so there is no clear technical necessity forcing a live test.
- Russian statements have framed any resumption as strictly reciprocal to US action, and no such US test has occurred as of August 2026.
What to watch
The most direct trigger between now and 31 December 2026 would be new satellite imagery or reporting on activity at Novaya Zemlya from arms-control monitoring groups. The expiration of New START on 5 February 2026 removes the last major bilateral treaty limiting US and Russian strategic arsenals and is worth watching for any accompanying statements from Moscow or Washington. Any US decision to conduct or announce its own nuclear test would be significant given Russian officials' repeated framing of resumption as reciprocal. Kremlin and Russian Ministry of Defense statements around major dates, including Victory Day commemorations and any NATO summit responses, are also worth tracking for shifts in rhetoric.
Trade this contract
Open on Polymarket
- gas covered
- no trading fee